1 / 16

Medicines Management Workstream Dr Vince Mak October 2010

This workstream aims to ensure optimal drug therapy for COPD patients, optimize the use of prescribed therapy, minimize waste, maximize value, and minimize variation in the cost of respiratory medication in England.

newd
Download Presentation

Medicines Management Workstream Dr Vince Mak October 2010

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Medicines Management Workstream Dr Vince Mak October 2010

  2. Objectives • Ensure Optimal drug therapy for COPD patients • Optimise use of prescribed therapy • Minimise waste – Maximise value • Minimise variation

  3. Cost of Respiratory Medication in England Source: NHS Information Centre

  4. Volume of prescriptions is low Source: NHS Information Centre

  5. Cost per item is high Source: NHS Information Centre

  6. Respiratory Medications are costly • Seretide (all) is the most expensive drug in UK (£344 million/yr) • Seretide 250 Evohaler is the most expensive individual item for NHS (£165million/yr) – second is atorvastatin • Symbicort 200 is 5th most expensive item for NHS (£80 million/yr) Source: www.drugtariff.co.uk Sourced Aug 2010

  7. Seretide by device

  8. COPD vs Asthma

  9. Tiotropium prescriptions in London Source: EPACT Jun2010

  10. Seretide prescription in London Source: Source: EPACT Jun2010

  11. Tiotropium as COPD surrogate marker • Total spend on Tiotropium in London for 1 year (2009/10) was approx £10.5 million • At on average £35/item = 300,000 units dispensed in London • Total spend on Seretide 250 evohaler for same period was roughly £16 million • At average of £60/item = 266,666 units dispensed • ?How much Seretide 250 may be accounted for by prescribing for COPD.

  12. Optimise therapy • Ensure all patients with COPD are on the appropriate therapy for the stage of their disease • New NICE guidance 2010

  13. Optimise use of medicines • Ensure all patients with COPD are using an appropriate inhaler device (spacer or DPI) • Ensure compliance • Ensure correct technique • Ensuring safety (steroid cards for high dose ICS/combinations)

  14. Minimise waste – Maximise value • Awareness of high cost of medications (healthcare professionals and patients) • If medications appropriate - use of cost effective evidence based option (e.g. Plain prednisolone vs EC – potential £2 million saving per year in London) • Ensure compliance • Avoid duplicate prescribing

  15. Minimise variation • Data suggests that across London after allowing for prevalence of COPD – there is large variation in: • Use of high dose inhaled steroids alone • Use of tiotropium • Use of combination therapy • Choice of combination therapy

  16. Next Steps • Understand the data • Understand the causes of variation • Find and promote examples of good practice (work with LIP and QIPP programs) • Disseminate information to healthcare professionals, patient groups, carers and patients

More Related